Quantification of muscle pathology in infantile Pompe disease

被引:19
|
作者
Schaenzer, Anne [1 ]
Kaiser, Ann-Kathrin [1 ]
Muehlfeld, Christian [2 ]
Kulessa, Martin [1 ]
Paulus, Werner [3 ]
von Pein, Harald [4 ]
Rohrbach, Marianne [5 ]
Viergutz, Lara [1 ]
Mengel, Eugen [6 ]
Marquardt, Thorsten [7 ]
Neubauer, Bernd [8 ]
Acker, Till [1 ]
Hahn, Andreas [8 ]
机构
[1] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany
[2] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany
[3] Univ Med Ctr, Inst Neuropathol, Munster, Germany
[4] Univ Med Ctr JGU Univ, Dept Neuropathol, Mainz, Germany
[5] Univ Childrens Hosp, Childrens Res Ctr, Div Metab, Zurich, Switzerland
[6] Univ Med Ctr JGU Univ, Villa Metab, Mainz, Germany
[7] Westfal Wilhelms Univ, Dept Pediat, Munster, Germany
[8] Justus Liebig Univ, Dept Child Neurol, Giessen, Germany
关键词
Pompe disease; Glycogen storage disease type II; Enzyme replacement therapy; Lysosomal storage disease; Acid maltase deficiency; Autophagy; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CLASSIC INFANTILE; CRIM STATUS; AUTOPHAGY;
D O I
10.1016/j.nmd.2016.10.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of enzyme replacement therapy (ERT) in infantile Pompe disease are variable, necessitating the identification of biomarkers to assess the severity of disease and response to ERT. The aims of this study were to investigate whether quantification of muscle pathology in infantile Pompe disease prior to and during ERT is feasible at the light microscope, and to develop a score that summarizes the degree of muscle pathology in a comprehensive manner from PAS-stained resin sections alone. We, therefore, determined glycogen load, extent of muscle fibre disruption, and amount of autophagic vacuoles in resin-embedded muscle biopsy specimens from 11 infantile Pompe patients and 2 with early childhood phenotype by quantitative methods, correlated the findings with ultrastructural analyses, compared PAS-stained resin sections with conventional PAS-stained cryosections, and related the quantified degree of muscle damage from infantile patients to the effects of ERT. Comparison of electron and light microscopic findings demonstrated that important alterations of skeletal muscle morphology can also be depicted by examining PAS stained resin sections. Infantile patients with good response to ERT had lower muscle pathology score values prior to and during ERT than those with moderate and poor response, but the number of tissue samples available for evaluation was limited. These findings suggest that quantification of muscle pathology by analysing PAS stained resin sections is in principle feasible and useful to monitor disease progression and therapy response. These results have to be validated by investigating a larger group of patients. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [31] Replacing acid α-glucosidase in Pompe disease:: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers
    Raben, N
    Fukuda, T
    Gilbert, AL
    de Jong, D
    Thurberg, BL
    Mattaliano, RJ
    Meikle, P
    Hopwood, JJ
    Nagashima, K
    Nagaraju, K
    Plotz, PH
    MOLECULAR THERAPY, 2005, 11 (01) : 48 - 56
  • [32] A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers
    van den Berg, Linda E. M.
    de Vries, Juna M.
    Verdijk, Robert M.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    van Doorn, Pieter A.
    NEUROMUSCULAR DISORDERS, 2011, 21 (03) : 232 - 234
  • [33] Pompe disease: what are we missing?
    Schoser, Benedikt
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (13)
  • [34] The Outcome of Infantile Onset Pompe Disease in South of Iran
    Moravej, Hossein
    Karamizadeh, Zohre
    Paran, Maryam
    IRANIAN JOURNAL OF PEDIATRICS, 2016, 26 (01)
  • [35] Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease
    Harrison N. Jones
    Carolyn W. Muller
    Min Lin
    Suhrad G. Banugaria
    Laura E. Case
    Jennifer S. Li
    Gwendolyn O’Grady
    James H. Heller
    Priya S. Kishnani
    Dysphagia, 2010, 25 : 277 - 283
  • [36] Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study
    Peng, Steven Shinn-Forng
    Hwu, Wuh-Liang
    Lee, Ni-Chung
    Tsai, Fuu-Jen
    Tsai, Wen-Hui
    Chien, Yin-Hsiu
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [37] Evaluating avalglucosidase alfa for the management of late-onset Pompe disease
    Angelini, Corrado
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (03) : 259 - 266
  • [38] A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells
    Yoshida, Takeshi
    Awaya, Tomonari
    Jonouchi, Tatsuya
    Kimura, Ryo
    Kimura, Shigemi
    Era, Takumi
    Heike, Toshio
    Sakurai, Hidetoshi
    SCIENTIFIC REPORTS, 2017, 7
  • [39] Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy
    Winkel, LPF
    Kamphoven, JHJ
    Van Den Hout, HJMP
    Severijnen, LA
    Van Doorn, PA
    Reuser, AJJ
    Van Der Ploeg, AT
    MUSCLE & NERVE, 2003, 27 (06) : 743 - 751
  • [40] The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile-and adult-onset patients
    Feeney, Erin J.
    Austin, Stephanie
    Chien, Yin-Hsiu
    Mandel, Hanna
    Schoser, Benedikt
    Prater, Sean
    Hwu, Wuh-Liang
    Ralston, Evelyn
    Kishnani, Priya S.
    Raben, Nina
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2